FDA hones activities amid shutdown, but impact on drugmakers appears limited so far
A regulatory consultant said his clients had not experienced any significant disruption, and the agency has been responsive to inquiries.
The Weinberg Group
A regulatory consultant said his clients had not experienced any significant disruption, and the agency has been responsive to inquiries.